+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Tissue Engineered Skin Substitutes Market by Product (Biological, Biosynthetic, Synthetic), Application (Acute Wounds, Chronic Wounds), End Use - Forecast 2024-2030- Product Image
Global Tissue Engineered Skin Substitutes Market by Product (Biological, Biosynthetic, Synthetic), Application (Acute Wounds, Chronic Wounds), End Use - Forecast 2024-2030- Product Image
Sale

Global Tissue Engineered Skin Substitutes Market by Product (Biological, Biosynthetic, Synthetic), Application (Acute Wounds, Chronic Wounds), End Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5612888
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tissue Engineered Skin Substitutes Market size was estimated at USD 1.12 billion in 2023, USD 1.25 billion in 2024, and is expected to grow at a CAGR of 12.65% to reach USD 2.58 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tissue Engineered Skin Substitutes Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tissue Engineered Skin Substitutes Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tissue Engineered Skin Substitutes Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Beckman Coulter, Inc., Convatec Group PLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KCI Licensing, Inc., Mallinckrodt PLC, Medline Industries, Inc, Medtronic PLC, Merck KGaA, MiMedx Group Inc., Novartis AG, Organogenesis, Inc., Regenicin, Inc., Sanofi S.A., Smith & Nephew PLC, The 3M Company, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Tissue Engineered Skin Substitutes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Biological
    • Biosynthetic
    • Synthetic
  • Application
    • Acute Wounds
      • Burn Injuries
      • Surgery & Trauma
    • Chronic Wounds
      • Diabetic Foot Ulcers
      • Other Chronic Wounds
      • Pressure Ulcers
      • Venous Leg Ulcers
  • End Use
    • Hospitals
    • Wound Care Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Tissue Engineered Skin Substitutes Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tissue Engineered Skin Substitutes Market?
  3. What are the technology trends and regulatory frameworks in the Tissue Engineered Skin Substitutes Market?
  4. What is the market share of the leading vendors in the Tissue Engineered Skin Substitutes Market?
  5. Which modes and strategic moves are suitable for entering the Tissue Engineered Skin Substitutes Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Tissue Engineered Skin Substitutes Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of acute and chronic wounds
5.1.1.2. Increased demand for skin grafts
5.1.1.3. Advances in skin regeneration technology
5.1.2. Restraints
5.1.2.1. Limited ability to reproduce skin appendages
5.1.3. Opportunities
5.1.3.1. Technological advancements and R&D investment in healthcare
5.1.3.2. Public-private alliance to promote and increase penetration in market
5.1.4. Challenges
5.1.4.1. Lack of supportive reimbursement policies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Tissue Engineered Skin Substitutes Market, by Product
6.1. Introduction
6.2. Biological
6.3. Biosynthetic
6.4. Synthetic
7. Tissue Engineered Skin Substitutes Market, by Application
7.1. Introduction
7.2. Acute Wounds
7.3.1. Burn Injuries
7.3.2. Surgery & Trauma
7.3. Chronic Wounds
7.4.1. Diabetic Foot Ulcers
7.4.2. Other Chronic Wounds
7.4.3. Pressure Ulcers
7.4.4. Venous Leg Ulcers
8. Tissue Engineered Skin Substitutes Market, by End Use
8.1. Introduction
8.2. Hospitals
8.3. Wound Care Centers
9. Americas Tissue Engineered Skin Substitutes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Tissue Engineered Skin Substitutes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Tissue Engineered Skin Substitutes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Bayer AG
13.1.2. Beckman Coulter, Inc.
13.1.3. Convatec Group PLC
13.1.4. Integra LifeSciences Corporation
13.1.5. Johnson & Johnson Services, Inc.
13.1.6. KCI Licensing, Inc.
13.1.7. Mallinckrodt PLC
13.1.8. Medline Industries, Inc
13.1.9. Medtronic PLC
13.1.10. Merck KGaA
13.1.11. MiMedx Group Inc.
13.1.12. Novartis AG
13.1.13. Organogenesis, Inc.
13.1.14. Regenicin, Inc.
13.1.15. Sanofi S.A.
13.1.16. Smith & Nephew PLC
13.1.17. The 3M Company
13.1.18. Thermo Fisher Scientific, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET RESEARCH PROCESS
FIGURE 2. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2023 VS 2030
FIGURE 3. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET DYNAMICS
FIGURE 7. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 12. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOSYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 12. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BURN INJURIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SURGERY & TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 16. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY OTHER CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY VENOUS LEG ULCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 21. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY WOUND CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 39. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 42. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 43. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 66. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 69. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 70. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 71. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 74. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 75. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 111. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 132. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 137. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 147. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 157. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 160. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 161. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 172. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 177. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 180. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 181. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 182. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 185. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 186. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 217. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 232. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 233. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET LICENSE & PRICING

Companies Mentioned

  • Bayer AG
  • Beckman Coulter, Inc.
  • Convatec Group PLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KCI Licensing, Inc.
  • Mallinckrodt PLC
  • Medline Industries, Inc
  • Medtronic PLC
  • Merck KGaA
  • MiMedx Group Inc.
  • Novartis AG
  • Organogenesis, Inc.
  • Regenicin, Inc.
  • Sanofi S.A.
  • Smith & Nephew PLC
  • The 3M Company
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.58 Billion
Compound Annual Growth Rate12.6%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Tissue Engineered Skin Substitutes - Global Strategic Business Report - Product Image

Tissue Engineered Skin Substitutes - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Global Tissue Engineered Skin Substitutes Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis - Product Image

Global Tissue Engineered Skin Substitutes Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • Report
  • 212 Pages
  • Global
From
Tissue Engineered - Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 - Product Image

Tissue Engineered - Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033

  • Report
  • Global
From
Global Tissue-engineered Skin Substitute Growth Opportunities - Product Image

Global Tissue-engineered Skin Substitute Growth Opportunities

  • Report
  • 78 Pages
  • Global
From
Global Biological Skin Substitutes Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Biological Skin Substitutes Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 183 Pages
  • Global
From

About the Market

The Skin Substitute market within the context of Wound Care is a rapidly growing sector of the medical industry. It is composed of products that are used to replace or regenerate lost or damaged skin. These products are used to treat a variety of wounds, including burns, ulcers, and other skin injuries. Skin substitutes are designed to provide a protective barrier, promote healing, and reduce the risk of infection. They are also used to improve the appearance of scars and other skin defects. Skin substitutes are typically made from a variety of materials, including collagen, hyaluronic acid, and other natural and synthetic materials. These materials are designed to mimic the properties of natural skin, such as elasticity, strength, and water-resistance. The Skin Substitute market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Smith & Nephew, ConvaTec, Mölnlycke Health Care, Integra LifeSciences, and Acelity. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.